Antitumor Necrosis Factor-like Ligand 1A Therapy Targets Tissue Inflammation and Fibrosis Pathways and Reduces Gut Pathobionts in Ulcerative Colitis. Issue 3 (2nd March 2022)

• Record Type: Journal Article
• Authors: Hassan-Zahraee, Mina; Ye, Zhan; Xi, Li; Baniecki, Mary Lynn; Li, Xingpeng; Hyde, Craig L; Zhang, Jenny; Raha, Nancy; Karlsson, Fridrik; Quan, Jie; Ziemek, Daniel; Neelakantan, Srividya; Lepsy, Christopher; Allegretti, Jessica R; Romatowski, Jacek; Scherl, Ellen J; Klopocka, Maria; Danese, Silvio; Chandra, Deepa E; Schoenbeck, Uwe; Vincent, Michael S; Longman, Randy; Hung, Kenneth E
• Is Part Of: Inflammatory bowel diseases. Volume 28:Issue 3(2022)
• Publication Date: 2022-03-02
• Subjects: TL1A inhibition -- transcriptional response -- inflammatory bowel disease -- ulcerative colitis; Inflammatory bowel diseases -- Periodicals; Colitis, Ulcerative -- Periodicals; Crohn Disease -- Periodicals; Inflammatory Bowel Diseases -- Periodicals; 616.344
• DOI: 10.1093/ibd/izab193
• Languages: English
• ISSNs: 1078-0998